Mem Inst Oswaldo Cruz, Rio de Janeiro, VOLUME 118 | 2023
Research Articles

Relevance of national, regional and global virome projects on pandemics prediction, prevention, and control: a social network analysis of GVP-citing articles

Bruna de Paula Fonseca1,2, Carlos Medicis Morel1,2,+

1Fundação Oswaldo Cruz-Fiocruz, Centro de Desenvolvimento Tecnológico em Saúde, Rio de Janeiro, RJ, Brasil
2Fundação Oswaldo Cruz-Fiocruz, Centro de Desenvolvimento Tecnológico em Saúde, Instituto Nacional de Ciência e Tecnologia de Inovação em Doenças de Populações Negligenciadas, Rio de Janeiro, RJ, Brasil

DOI: 10.1590/0074-02760230116
935 views 1076 downloads
Print Email PDF Supplementary data
ABSTRACT

BACKGROUND The Global Virome Project (GVP) was proposed in 2018 as an evolution of the USAID PREDICT project and was presented as a “collaborative scientific initiative to discover zoonotic viral threats and stop future pandemics”. The immediate response was mixed, with public health and scientific communities representatives showing skepticism, if not direct opposition.
OBJECTIVES The economic, social, and health consequences of the coronavirus disease 2019 (COVID-19) pandemic demonstrated how unprepared the world was in the face of new pandemics. This paper analyses the impact of the GVP on the scientific and public health communities.
METHODS Published scientific articles that cited the two 2018 seminal publications proposing the project were analysed using social network analysis methods.
FINDINGS Encompassing the periods before and after the onset of the Covid-19 pandemic, the results indicate that (i) the concepts of the GVP have received more support than opposition in the scientific literature; (ii) its foundations should be updated to address the specific criticisms.
MAIN CONCLUSIONS Shifting focus to national virome projects can provide tangible, regional benefits that can positively contribute towards a consensus on achieving a high level of preparedness for the ever-present possibility of the following global viral pandemic.

key words: social network analysis public health pandemic global virome project
REFERENCES
01. The World Bank. World Bank. 2022. World development report 2022: FINANCE for an equitable recovery. Available from: https://www.worldbank.org/en/publication/wdr2022.
02. Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet. 2012; 380(9857): 1956-65.
PubMed
03. Christaki E. New technologies in predicting, preventing, and controlling emerging infectious diseases. Virulence. 2015; 6(6): 558-65.
PubMed
04. Keusch GT, Amuasi JH, Anderson DE, Daszak P, Eckerle I, Field H, et al. Pandemic origins and a one health approach to preparedness and prevention: solutions based on SARS-CoV-2 and other RNA viruses. Proc Natl Acad Sci. 2022; 119(42): e2202871119.
PubMed
05. Dye C. The great health dilemma: is prevention better than cure? Oxford University Press; 2021. Available from: https://ora.ox.ac. uk/objects/uuid:11cc474b-68aa-4ad3-a608-8edd4f32ee96.
06. PREDICT Consortium. Reducing pandemic risk, promoting global health. One Health Institute, University of California, Davis. 2014; 359 pp.
07. Global Virome Project. Preparing for the next pandemic. 2016 [cited 2023 Feb 25]. How the global virome project began: the bellagio initiative. Available from: https://www.globalviromeproject. org/our-history.
08. Carroll D, Daszak P, Wolfe ND, Gao GF, Morel CM, Morzaria S, et al. The Global Virome Project. Science. 2018; 359(6378): 872-4.
PubMed
09. Carroll D, Watson B, Togami E, Daszak P, Mazet JA, Chrisman CJ, et al. Building a global atlas of zoonotic viruses. Bull World Health Organ. 2018; 96(4): 292-4.
PubMed
10. Holmes EC, Rambaut A, Andersen KG. Pandemics: spend on surveillance, not prediction. Nature. 2018; 558(7709): 180.
PubMed
11. Radicchi F, Fortunato S, Vespignani A. Citation networks. In: Scharnhorst A, Börner K, van den Besselaar P, editors. Models of science dynamics: encounters between complexity theory and information sciences. Berlin, Heidelberg: Springer; 2012. p. 233-57. (Understanding Complex Systems). Available from: https://doi. org/10.1007/978-3-642-23068-4_7.
12. West DF, Vilhena DA. A network approach to scholarly evaluation. In: Beyond bibliometrics: harnessing multidimensional indicators of scholarly impact. The MIT Press; 2014. Available from: https://doi.org/10.7551/mitpress/9445.003.0012.
13. Morel CM, Serruya SJ, Penna GO, Guimarães R. Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases. PLoS Negl Trop Dis. 2009; 3(8): e501. doi: 10.1371/journal. pntd.0000501.
PubMed
14. Vasconcellos AG, Morel CM. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil. PLoS One. 2012; 7(10): e45569.
PubMed
15. Albuquerque PC, Zicker F, Fonseca BP. Advancing drug repurposing research: trends, collaborative networks, innovation and knowledge leaders. Drug Discov Today. 2022; 27(12): 103396.
PubMed
16. Fonseca BP, Albuquerque PC, Saldanha RF, Zicker F. Geographic accessibility to cancer treatment in Brazil: a network analysis. Lancet Reg Health Am. 2022; 7: 100153.
PubMed
17. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARSCoV- 2. Nat Microbiol. 2020; 5(4): 536-44.
PubMed
18. Lipkin WI. The changing face of pathogen discovery and surveillance. Nat Rev Microbiol. 2013; 11(2): 133-41.
PubMed
19. NSF - National Science Foundation. Predictive intelligence for pandemic prevention phase I: development grants (PIPP Phase I). 2021. Available from: https://beta.nsf.gov/funding/opportunities/ predictive-intelligence-pandemic-prevention-phase.
20. Fulci V, Carissimi C, Laudadio I. COVID-19 and preparing for future ecological crises: hopes from metagenomics in facing current and future viral pandemic challenges. OMICS J Integr Biol. 2021; 25(6): 336-41.
PubMed
21. Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020; 324(15): 1495-6.
PubMed
22. Kaufer AM, Theis T, Lau KA, Gray JL, Rawlinson WD. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a risk group 3 biological agent. Pathology (Phila). 2020; 52(7): 790-5.
PubMed
23. Ellwanger JH, Chies JAB. Keeping track of hidden dangers - The short history of the Sabiá virus. Rev Soc Bras Med Trop. 2017; 50: 03-8.
PubMed
24. Nastri AC, Duarte-Neto AN, Casadio LVB, Souza WM, Claro IM, Manuli ER, et al. Understanding Sabiá virus infections (Brazilian mammarenavirus). Travel Med Infect Dis. 2022; 48: 102351.
PubMed
25. Lentzos F, Koblentz GD, Ameneiro M, Earnhardt B, Houser R, Rodgers J, et al. Global bioLabs report 2023. Londres: The Bulletin of the Atomic Scientists, George Mason University School of Policy and Government,King’s College London; 2023. p. 30. Available from: https://www.globalbiolabs.org/s/KCL0680_Bio- Labs-Report_Digital.pdf.
26. Souza TML, Morel CM. The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control. Biosaf Health. 2021; 3(1): 1-3.
PubMed
27. Whitlock WL. Detection, prediction, and surveillance. In: DC Keynes, JL Burstein, RB Schwartz, RE Swienton, editors. Medical response to terrorism preparedness and clinical practice. Philadelphia: Lippincott Williams & Wilkins; 2005. p. XIII + 449.
28. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The sverdlovsk anthrax outbreak of 1979. Science. 1994; 266(5188): 1202-8.
PubMed
29. Carbone AJ. Anthrax. In: DC Keyes, JL Burstein, RB Schwartz, RE Swienton, editors. Medical response to terrorism preparedness and clinical practice. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 56-69.
30. Harvey E, Holmes EC. Diversity and evolution of the animal virome. Nat Rev Microbiol. 2022; 20(6): 321-34.
PubMed
31. Preston E. School of veterinary medicine. 2019. What We’ve found. Available from: https://ohi.sf.ucdavis.edu/what-weve-found.
32. US Embassy Beijing. China’s interest in the global virome project presents an opportunity for global health cooperation. 2017. Available from: https://www.dropbox.com/s/e568bznckc4uoji/ AmEmbassyBeijingUS2017GVP.pdf?dl=0.
33. United States Senate. An analysis of the origins of the COVID-19 pandemic: interim report. 2022. p. 1-35. Available from: https:// www.help.senate.gov/imo/media/doc/report_an_analysis_of_ the_origins_of_covid-19_102722.pdf.
34. Possas C, Lourenço-de-Oliveira R, Tauil PL, Pinheiro FP, Pissinatti A, Cunha RV, et al. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Mem Inst Oswaldo Cruz. 2018; 113(10): e180278.
PubMed
35. Lacerda AB, del Castillo Saad L, Ikefuti PV, Pinter A, Chiaravalloti- Neto F. Diffusion of sylvatic yellow fever in the state of São Paulo, Brazil. Sci Rep. 2021; 11(1): 16277.
PubMed
36. Simmonds P, Adriaenssens EM, Zerbini FM, Abrescia NGA, Aiewsakun P, Alfenas-Zerbini P, et al. Four principles to establish a universal virus taxonomy. PLoS Biol. 2023; 21(2): e3001922.
PubMed
37. Ellwanger JH, Kaminski VL, Chies JAB. Emerging infectious disease prevention: Where should we invest our resources and efforts? J Infect Public Health. 2019; 12(3): 313-6.
PubMed

Financial support: FIOCRUZ and Instituto Nacional de Ciência e Tecnologia de Inovação em Doenças de Populações Negligenciadas through the CNPq (465313/2014-0 to CMM; 407060/2018-9 to BPF), FAPERJ (E 16/2014-INCT to CMM; SEI-260003/001550/2022 to BPF).
Acquisition of articles under paywall was made possible through the DT-1D Productivity Scholarship in Technological Development granted to CMM by CNPq (304001/2022-8).
+ Corresponding author: carlos.morel@fiocruz.br
ORCID https://orcid.org/0000-0003-2752-0009
Received 02 July 2023
Accepted 05 September 2023

HOW TO CITE
Fonseca BP, Morel CM. Relevance of national, regional and global virome projects on pandemics prediction, prevention, and control: a social network analysis of GVP-citing articles. Mem Inst Oswaldo Cruz. 2023; 118: e230116.

Our Location

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco 
sala 201, Manguinhos, 21040-900 
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This email address is being protected from spambots. You need JavaScript enabled to view it.

Support Program

logo iocb

logo governo federal03h 
faperj   cnpq capes

Site Map

Member Login